Diagnosing Pheochromocytoma
Initial biochemical testing should measure plasma free metanephrines or urinary fractionated metanephrines, as these tests demonstrate superior sensitivity (97%) compared to all other catecholamine measurements and are the recommended first-line diagnostic approach. 1
When to Suspect and Screen for Pheochromocytoma
The critical first step is recognizing clinical scenarios that warrant testing. Screen patients presenting with:
- Paroxysmal symptoms: The classic triad of profuse sweating, tachycardia, and severe headaches (present in ~51% of cases) 2
- Hypertension patterns: Paroxysmal, resistant, or early-onset hypertension (prevalence 0.2-0.6% in general hypertensive populations, but 1.7% in hypertensive children) 1
- Adrenal incidentalomas: Nearly 5% of incidentally discovered adrenal masses prove to be pheochromocytomas 1
- Hereditary predisposition: Family history or syndromic features (MEN2, VHL, neurofibromatosis, SDH mutations) - critical because >30% of cases are hereditary 1, 3
- Medication-provoked symptoms: Symptoms triggered by certain medications that interact with catecholamine pathways 1
Biochemical Confirmation: The Diagnostic Algorithm
Step 1: First-Line Testing
Measure either:
- Plasma free metanephrines, OR
- Urinary fractionated metanephrines (24-hour collection)
The Endocrine Society guideline provides compelling evidence from over 800 patients at NIH demonstrating 97% sensitivity for plasma metanephrines, vastly superior to the 47-74% sensitivity of catecholamine or VMA measurements 1. This superiority stems from continuous intratumoral production of metanephrines independent of episodic catecholamine release, making them more reliable markers 1.
Fifteen independent studies confirmed diagnostic accuracy with ROC curve areas ranging from 0.965 to 1.0 1. Urinary normetanephrine specifically shows 96.9% sensitivity 2.
Step 2: Managing Borderline Results
For moderate elevations of normetanephrine with uncertain significance:
- Perform clonidine suppression test to differentiate true endogenous hypersecretion from false positives 3
Common Pitfall to Avoid
Do not rely on direct catecholamine measurements (epinephrine, norepinephrine, dopamine) as initial tests - their sensitivity is significantly inferior because catecholamine release can be episodic, leading to false negatives in tumors with low or intermittent secretion 1.
Anatomical Localization After Biochemical Confirmation
Once biochemical diagnosis is established:
Primary imaging:
Functional imaging - reserve for specific scenarios:
- 123I-MIBG scintigraphy (83.7% sensitivity) 2 or 18F-FDG PET 6
- Indicated when: metastatic disease suspected, multifocal disease possible, extra-adrenal paraganglioma, or hereditary syndromes present 6
- Not necessary for patients >40 years, no family history, small (<3 cm) adrenal pheochromocytoma with negative genetic testing 6
The combination of platelet norepinephrine plus MIBG scintigraphy achieves 100% sensitivity, though this is rarely needed in routine practice 2.
Genetic Testing
Perform genetic testing in ALL patients with confirmed pheochromocytoma 1, 3. Over one-third have germline mutations, with implications for:
- Screening family members
- Predicting malignancy risk (SDHB mutations carry 31-71% malignancy risk) 6
- Guiding surveillance protocols
- Identifying multifocal disease risk (hereditary cases present younger with multifocal disease) 1
Additional Mandatory Evaluation
Cardiological assessment is essential to identify catecholamine-induced cardiovascular complications including myocarditis, cardiomyopathy, and target organ damage that may be present even before diagnosis 3, 7.
Critical Clinical Context
Autopsy studies reveal 0.05-0.1% of patients have undiagnosed pheochromocytomas at death 1, emphasizing the importance of maintaining high clinical suspicion. The diagnosis is frequently missed because presentations are highly variable and can mimic numerous other conditions 5. Recognition of the possibility is more important than any single test - without clinical suspicion, even the best biochemical tests won't be ordered 1.